EDGAR Filing Documents for 0001628280-24-028534

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001628280-24-028534

Filing Date

2024-06-17

Accepted

2024-06-17 17:15:37

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	kerostherapeutics-424b5.htm	424B5	365383
2	EX-FILING FEES	exhibit107-atmprosupp2024.htm	EX-FILING FEES	29665
3		keroslogo.jpg	GRAPHIC	30676
4		prospectuscover.jpg	GRAPHIC	8995
	Complete submission text file	0001628280-24-028534.txt		450852

Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421

Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297

Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

IRS No.: 811173868 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-279094 | Film No.: 241049260
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)